Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NANOSPHERE INC | 3,580,180 | reported | 29 Jul 2011 | tx 8+5,063,236−4,847,192 |
| MAP Pharmaceuticals, Inc. | 2,999,526 | reported | 11 Oct 2007 | tx 5+2,999,526−2,285,364 |
| MPM ACQUISITION CORP | 1,943,241 | reported | 05 Jun 2014 | tx 3+581,880 |
| DOMINOS PIZZA INC | 1,003,887 | reported | 11 Mar 2010 | tx 3−480,537 |
| Targanta Therapeutics Corp. | 0 | reported | 15 Oct 2007 | tx 5+2,771,682−165,912 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jun 2014 | PURCHASE | MPM ACQUISITION CORP | 500,000 | 8.00 USD | first after silence |
| 28 Jul 2011 | SALE | NANOSPHERE INC | 862,457 | 2.13 USD | |
| 29 Jul 2011 | SALE | NANOSPHERE INC | 30,400 | 2.08 USD | |
| 14 Dec 2011 | PURCHASE | MPM ACQUISITION CORP | 40,940 | 81.42 USD | deriv |
| 18 Nov 2011 | PURCHASE | MPM ACQUISITION CORP | 40,940 | 81.42 USD | derivfirst after silence |
| 11 Mar 2010 | SALE | DOMINOS PIZZA INC | 66,095 | 13.65 USD | |
| 10 Mar 2010 | SALE | DOMINOS PIZZA INC | 152,331 | 13.75 USD | |
| 04 Mar 2010 | SALE | DOMINOS PIZZA INC | 262,111 | 13.63 USD | |
| 15 Oct 2007 | CONVERSION | Targanta Therapeutics Corp. | 2,092,987 | 0.00 USD | |
| 15 Oct 2007 | PURCHASE | Targanta Therapeutics Corp. | 575,000 | 10.00 USD | |
| 15 Oct 2007 | CONVERSION | Targanta Therapeutics Corp. | 82,956 | 0.00 USD | deriv |
| 15 Oct 2007 | CONVERSION | Targanta Therapeutics Corp. | 82,956 | 10.45 USD | deriv |
| 15 Oct 2007 | CONVERSION | Targanta Therapeutics Corp. | 103,695 | 10.45 USD | deriv |
| 05 Oct 2007 | PURCHASE | MAP Pharmaceuticals, Inc. | 600,000 | 12.00 USD | |
| 11 Oct 2007 | OTHER | MAP Pharmaceuticals, Inc. | 114,162 | 14.50 USD | |
| 11 Oct 2007 | CONVERSION | MAP Pharmaceuticals, Inc. | 2,285,364 | — | |
| 11 Oct 2007 | CONVERSION | MAP Pharmaceuticals, Inc. | 1,164,389 | 14.50 USD | deriv |
| 11 Oct 2007 | CONVERSION | MAP Pharmaceuticals, Inc. | 1,120,975 | 14.50 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 05 Jun 2014.